Search PubMed⌕ Search

SEARCH · Search PubMed

Results for “Production”

Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 361 records · Page 20Linked to original sources
PubMed1991

Effects of alternative lamb production systems, terminal sire breed, and maternal line on ewe productivity and its components.

The 4 yr productivity of 25% (QF; n = 533) and 50% (HF; n = 531) Finnsheep ewes exposed to either Suffolk or Columbia rams in one of three production systems was monitored to test the effects of system, terminal sire breed, maternal line, and their interactions on annual market lamb production. Ewe lambs and yearlings were randomly assigned to either a high-input accelerated lambing system (HIGH), a high-input annual system (MED), or a low-input annual system (LOW). Nursery facilities were available for weak lambs or those born in triplet or more births for the HIGH and MED but not for the LOW systems. Accelerated lambing protocol required early weaning. Sex-adjusted lamb weaning weights were corrected to within-system mean ages of 42 d for HIGH and 70 d for MED and LOW. The HIGH ewes weaned 1.55 lambs per year compared with 1.46 for MED and 1.18 for LOW (P less than .01). However, because of early weaning, HIGH yielded the lowest weight of weaned lamb per year. The MED ewes weaned 5.9 and 11.1 more kilograms of lamb per year than the LOW and HIGH ewes, respectively (P less than .01). The HIGH system may be economically feasible if young lambs could be inexpensively grown to feeder or market lamb weight. The HIGH ewes did not, however, increase lamb numbers in proportion to increased exposures compared with the annual systems. Breed-group effects for ewe productivity (kilogram of lamb weaned per ewe per year) were consistent across management systems, although some interactions among breed group and system were present for components of productivity. Suffolk rams yielded an advantage of 1.6 kg of weaned lamb per exposure over Columbia rams (P less than .05) due to a 3% better lamb survival (P less than .01) and heavier weaning weight, especially in the LOW system. The HF ewes weaned .1 more lambs per exposure than QF ewes (P less than .01); .06 of the lambs were nursery-reared. However, lambs from HF ewes had a 2% lower survival rate (P less than .05) and were 1.4 kg lighter at weaning (P less than .01), so overall productivity among HF and QF ewes was similar.

Animal Husbandry↗
PubMed2006

Use of the in vitro cumulative gas production technique for pigs: an examination of alterations in fermentation products and substrate losses at various time points.

An experiment was conducted to examine changes in VFA and ammonia concentrations at different time points using 4 fermentable carbohydrate-rich feed ingredients as substrates and feces of unweaned piglets as inoculum. Fecal inoculum was collected, pooled, and mixed from 9 specially raised (no creep feed or antibiotics) crossbred piglets at 3 wk of age. Inulin, lactulose, molasses-free sugar beet pulp, and wheat starch were used as substrates and were fermented in vitro for 72 h (3 replicates per substrate). Cumulative gas production was measured as an indicator of the kinetics of fermentation. In addition, 3 bottles of substrate per time point with similar contents (amounts of substrate, inoculum, and media) were incubated but were allowed to release their gas throughout incubation. For these latter bottles, fermentation fluid was sampled at incubation time points including every hour between 1 and 24 h and at 48 h, and fermentation end products (VFA, lactate, and ammonia) and OM disappearance were measured. Dry matter and ash were analyzed from the postfermentative samples. The pH of the contents from these bottles was also recorded. The correlation in time between fermentation end products and cumulative gas produced was determined. The results showed that the prolongation of fermentation to 72 h, especially in the case of fast-fermenting inulin and lactulose, may lead to a different end product profile (P < 0.001) compared with the profile observed at the time at which most of the substrate has disappeared. Therefore, we concluded that the fermentation product profile at the end of in vitro fermentation at a specific time point cannot be used to compare fermentability of carbohydrate sources with different fermentation kinetics in terms of gas production.

Ammonia↗
PubMed1986

In vitro fermentation of sugars, grains, and by-product feeds in relation to initiation of ruminal lactate production.

In vitro fermentations of various sugars, grains, and by-products were conducted to investigate the relationships between soluble carbohydrates and initiation of ruminal lactate production. Fermentation of hexose sugars, both monosaccharides and disaccharides, resulted in greater accumulation of lactate than did fermentation of pentoses. Results of fermentation of grains and by-products, in order of greatest to least potential to produce lactic acid, were steam-flaked barley = barley = wheat greater than moisture corn = sorghum grain. Water-soluble fractions of the grains and by-products were more rapidly fermented to lactate than the insoluble fractions. Combining 10% soluble fractions from wheat, barley, and steam-flaked barley with 90% insoluble fractions from corn resulted in significant increases in lactate concentration. Analysis of sugar composition of these water soluble materials indicated that monosaccharides and disaccharides constitute 23 to 46% by weight. Data suggest that water-soluble materials play a role in initiation of lactate production from grains, and further production is dependent on starch fermentability.

Animal Feed↗
PubMed1989

Production of a factor (CIF) from normal fibroblast cells inhibiting tumor necrosis factor/cachectin production.

Murine embryonic fibroblast cells produce a factor designated cytotoxin-inhibiting factor (CIF) which inhibits tumor necrosis factor (TNF) and interleukin 1 production as well as tumoricidal activity by lipopolysaccharide-activated macrophages. This study determines the physiologic conditions of CIF production in serum-free medium. CIF production was largely dependent upon the presence of lipopolysaccharide. A quantitative correlation between fibroblast cell number, lipopolysaccharide concentration, and incubation time was established. Evidence is presented that CIF inhibited the production or release of TNF. CIF did not destroy TNF after production and release nor did it sequester secreted TNF. The supernatant fluids which inhibited TNF production did not suppress the capability of resting macrophages to phagocytize opsonized sheep erythrocytes, suggesting that only functions expressed in the activated state are inhibited.

Animals↗
PubMed1984

Physiological profile of caged layers during one production year, molt, and postmolt: egg production, egg shell quality, liver, femur, and blood parameters.

A longitudinal study of a flock of Single Comb White Leghorn pullets was initiated at 19 weeks of age (preproduction) and continued through a production year, a forced molt, and for 4 months of postmolt production. A representative sample of hens was obtained at 12-week intervals during the first year and at subsequent selected times. Liver lipid, femur weight, femur volume, femur density, egg weight, shell weight, percent shell, milligrams shell/square centimeter of shell surface area, serum calcium, serum phosphorus, and serum alkaline phosphatase were determined. Percent hen-day production peaked at 90% and then declined by .6 to .7% each week during the first production year. After molting, percent hen-day egg production peaked at 80% and declined .9% per week over the subsequent 20 weeks. Egg weight increased continually during the first production year. Shell weight was greatest immediately postmolt; thereafter it declined. Shell thickness was greatest at 31 weeks of age and declined throughout the first year. After molting, the shell thickness of 83-week-old hens was similar to values of hens about 37 weeks of age. Serum calcium and phosphorus of laying hens were influenced by age, feed intake and environmental temperature. The lowest values occurred during hot weather. Liver lipid was lowest in nonlaying hens (17 to 20%) and was approximately 42% of dry weight in laying hens. Femur density was greater in laying than nonlaying hens.

Alkaline Phosphatase↗
PubMed2006

The novel cytokine p43 induces IL-12 production in macrophages via NF-kappaB activation, leading to enhanced IFN-gamma production in CD4+ T cells.

Recently, we determined that p43, an auxiliary factor of mammalian multiaminoacyl-tRNA synthetases, is secreted, and functions as a novel pleiotropic cytokine. In this study, we have attempted to characterize the effects of p43 on the generation of IL-12 in mouse macrophages. p43 was determined to induce significant IL-12 production from mouse macrophages in a dose-dependent manner. The stimulatory effect of p43 on the activation of IL-12p40 promoter was mapped to a region harboring an NF-kappaB binding site. The nuclear extracts from the p43-stimulated macrophages exhibited profound NF-kappaB DNA-binding activity, as determined by the EMSA. In addition, the p43-stimulated IL-12 induction and NF-kappaB DNA-binding activity were significantly suppressed by caffeic acid phenethyl ester and BAY11-7082, both inhibitors of NF-kappaB activation, indicating that p43 induced the production of IL-12 in macrophages mainly via the activation of NF-kappaB. Importantly, p43 increased the level of IFN-gamma production in the Ag-primed lymph node cells, but had no effect on IL-4 levels. The addition of a neutralizing anti-IL-12p40 mAb to the cell cultures resulted in a decrease of the production of p43-enhanced IFN-gamma by the keyhole limpet hemocyanin-primed lymph node cells. Furthermore, coincubation with p43-pretreated macrophages enhanced the production of IFN-gamma by the keyhole limpet hemocyanin-primed CD4+ T cells, thereby indicating that p43 may enhance IFN-gamma expression in CD4+ T cells via the induction of IL-12 production in macrophages. These results indicate that p43 may play an essential role in the development of the Th1 immune responses associated with cancer immunotherapy and protective immunity against intracellular pathogens.

Animals↗
PubMedDate not supplied

Action against Vibrio cholerae O1 Tox+ of chemical products used in the lemon production.

Tucuman is the first lemon exporting province in Argentina and the fourth lemon exporter in the world. The present work was set up to study the survival of Vibrio cholerae O1 Tox+ after application of different chemical products used in the lemon production (from its cultivation until its packing). The following products were studied: copper oxychloride, benomil (a carbamate), active chlorine, sodium-o-phenylphenoate, guazatine (a polyamine mixture), imazalil (an imidazole) and fresh and dehydrated lemon peel. Using different dilutions of the products above mentioned antimicrobial tests were carried out with different exposure times against V. cholerae Serogroup O1, Biotype El Tor, Serotype Inaba. The microorganism was used at concentrations of 10(2), 10(4), 10(6) and 10(8) CFU ml-1, the latter one being considered as an infectious dose. The following results were obtained: 1) Active chlorine (chlorinated water) showed bactericidal activity at concentrations of 0.5 x 10(-1), 10(-1), y 2 x 10(-1) g l-1 after 10 min of exposure time. 2) Copper oxychloride, sodium-o-phenylphenoate, guazatine and imazalil showed bactericidal activity against V. cholerae at concentrations of 10(2) and 10(4) CFU ml-1. 3) Due to the fact that the fruit is successively sprayed with several chemical products during its cultivation, it could be proposed that the result of the successive treatments is superior to the result of a treatment with each of the individual products. This consideration should be taken into account when evaluating the eventual protection of the lemon.

Agriculture↗
PubMed2001

Comparative analysis of two controlled proliferation strategies regarding product quality, influence on tetracycline-regulated gene expression, and productivity.

Overexpression of the cyclin-dependent kinase inhibitor p27 and exposure to low temperature (30 degrees C) represent two strategies to establish controlled proliferation processes for production of therapeutic proteins using Chinese hamster ovary (CHO) cells. Here we analyze the effect of growth inhibition on the quality of the human model glycoprotein SEAP (secreted alkaline phosphatase) for both strategies in monoclonal CHO-derived cell lines. Separation of purified SEAP samples using two-dimensional gel electrophoresis showed that production by proliferation-controlled CHO cultures did not alter the overall integrity of the product. Further, oligosaccharide profiles were compared using HPEC-PAD analysis. No differences were detectable between SEAP profiles obtained from p27 growth-arrested and proliferating cultures. However, production at 30 degrees C led to a significant increase in the degree of sialylation, an effect that is generally considered beneficial for the in vivo efficacy of protein therapeutics. In the production context presented here, SEAP expression is controlled by the tetracycline- (tet) repressible gene regulation system. Here we show low temperature-induced upregulation of the tetracycline-dependent transactivator (tTA). This induction has been shown by Northern blot analysis to occur at the mRNA level and is independent of the promoters driving the transactivator. We also describe a novel bottleneck in productivity at low temperature found in p27 growth-arrested CHO cells cultivated at 30 degrees C.

Alkaline Phosphatase↗
PubMed2002

Development of serum-free media for cell growth and production of viruses/viral vaccines--safety issues of animal products used in serum-free media.

The development of media free of serum and animal or human proteins is of utmost importance for increasing the safety of biological produced for therapy and vaccination. The main drawback associated with the use of serum or animal-derived substances for animal cell technology is the potential introduction of contaminants and, in particular, adventitious agents into the process and thus potentially also into the final product. This fact led to an increased effort to replace serum-containing by serum-free media. In most cases, these media are supplemented with purified proteins, peptones, or hydrolysates, mainly of animal or human origin. Although such serum-free media are more defined than serum-containing media, the risk of the introduction of viruses by using animal-derived substances is still present, signifying that only a complete replacement of animal-derived substances by non-animal-derived products leads to a relatively safe serum-free medium. In several examples the potential of serum-free media and media free of any animal-derived component in supporting growth of cell lines of interest for virus production (such as Vero or MDCK) and production of viruses, and, in particular, of influenza virus for vaccine production, are presented and discussed with respect to the classical production processes.

Albumins↗
PubMed1999

Helicobacter pylori products upregulate neutrophil superoxide anion production.

Helicobacter pylori-neutrophil interactions may play a pathogenic role in H. pylori-induced gastritis and peptic ulcer disease. To understand these interactions, we explored the effects of H. pylori-derived products on neutrophil chemotaxis and superoxide anion production. H. pylori bacteria were cultured and supernatants fractionated. Neutrophil chemotactic activity was confirmed in the crude supernatants and in one fractionated peak corresponding to a previously described neutrophil chemotactic factor. H. pylori-derived crude supernatant, sonicate and all chromatography-derived peaks failed to directly stimulate neutrophil superoxide anion production. However, after pretreatment with sonicate, neutrophils demonstrated increased superoxide anion production (priming) following subsequent exposure to the secretagogue fmet-leu-phe. These results suggest that H. pylori products may attract neutrophils to the gastric mucosa without initially stimulating superoxide anion production or tissue injury. Oxygen radical-mediated gastric mucosal injury may subsequently result when these primed neutrophils undergo additional stimulation by as yet unidentified factors.

Chemotaxis, Leukocyte↗
PubMed1992

Epstein-Barr virus BCRF1 gene product (viral interleukin 10) inhibits superoxide anion production by human monocytes.

Due to its similar biological activities to interleukin 10 (IL-10), Epstein-Barr virus (EBV) BCRF1 gene product (viral IL-10: vIL-10) has recently been recognized as an analogue of authentic IL-10. Preincubation of human monocytes with vIL-10, like human IL-10, induced smaller amounts of interferon-gamma (IFN-gamma) mRNA in activated human peripheral blood mononuclear cells (PBMNCs) than nonpreincubation, indicating that vIL-10 acts principally on monocytes. Since the activation of monocytes and their generation of oxidative products are regulated by various cytokines, we examined the effects of vIL-10 on superoxide anion (O2-) production by human PBMNCs and monocytes. Not only PBMNCs but also monocytes preincubated with vIL-10 showed a smaller production of O2-. Inhibition was achieved in a dose-dependent fashion and increased gradually after incubation with vIL-10. Additions of IFN-gamma, macrophage colony-stimulating factor (M-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF), which prime monocyte activation and induce O2- production, were also affected by the reciprocal effect of vIL-10. Thus, vIL-10 production by EBV-infected cells may be involved in the development of EBV-related disorders.

Base Sequence↗
PubMed2003

The EAMG position on the regulation of existing products for treatment with special reference to named patient products (NPPs).

Allergen products have a long history in both diagnosis and management of allergic disease. It is emphasized that the availability of named patient products presents a valuable and indispensable option for the effective and safe treatment of patients suffering from IgE-mediated allergic diseases. A regulatory climate should be achieved in which these products can survive until a safe and effective alternative is borne out. Within the context of the paper the following definition is used: A named patient product or NPP is an allergen product, prepared with a specific reference number in accordance with a prescription for an individual patient, identified by the name of this patient and the reference number, and delivered after control of consistency with previous treatments. It is stressed that the standards of quality that hold for registered products are also applicable for named patient preparations which, for various reasons, can not be filed for registration. The paper frequently refers to a Position Paper that has recently been adopted by the European Allergen Manufacturers Group, the EAMG. The presentation breaks a lance for a concerted approach of the NPP-concept by striving at harmonization of legal, regulatory, manufacturing, and distribution conditions.

Allergens↗
PubMed2004

Autogenous vaccines: determining product need and antigen selection, production and testing considerations.

It is estimated that in the 12-month period from May 1999--April 2000 approximately $16.06 million in swine autogenous vaccines were sold in the United States. Swine influenza and PRRS vaccines accounted for over one-half of these sales. Usage patterns suggest USDA regulation covering the production and use of autogenous vaccines may be violated. A proposal for product use and selection criteria that may minimize the potential for abuse of autogenous regulations is described. Using a decision tree, the analysis considers issues such as availability of registered products, recognized strain variations and the current state of vaccine technology. Proposed testing and production scenarios are described that include food safety considerations, yet allow for the rapid production and testing required for autogenous products.

Antigens↗
PubMed2004

[Advanced oxidation protein products induce reactive oxygen species production in endothelial cells].

OBJECTIVE: To investigate the effect of advanced oxidation protein products (AOPP) on production of reactive oxygen species (ROS) in endothelial cells. METHODS: Human umbilical vein endothelial cell line ECV304 were stimulated with AOPP-modified bovine serum albumin (AOPP-BSA) prepared by oxidation of BSA with HOCl in vitro. ROS production in the cells was evaluated by kinetic measurement of dichlorofluoroscein (DCF) fluorescence produced by oxidation of an oxidant-sensitive dye 2,7-dichlorefluorescin (DCFH) using VICTOR 1420 multilabel counter. RESULTS: AOPP-BSA could induce ROS production in ECV304 cells time- and dose-dependently, and the quantity of ROS increased with the oxidation degree of BSA. Pretreatment of cells with a small-molecular-mass glutathione peroxidase mimic ebselen or NADPH oxidase inhibitor apocynin inhibited ROS production by 65% and 29% respectively. CONCLUSION: AOPP-BSA induces ROS production in endothelial cells, partially mediated by NADPH oxidase activation.

Cell Line↗
PubMed1992

Prostaglandin E2 production during hepatic regeneration downregulates Kupffer cell IL-6 production.

The liver possesses the remarkable ability to regenerate to its original size after a 70% partial hepatectomy. There has been little effort to characterize the Kupffer cells' role in this unique mammalian reparative physiologic phenomenon. The capacity of rat Kupffer cells (KC) isolated at specific intervals after partial hepatectomy to produce interleukin-6 (IL-6) and prostaglandin E2 (PGE2) in response to endotoxin was evaluated in standard RPMI-1640 (1200 microM L-arginine) and arginine-depleted RPMI-1640 (10 microM L-arginine) media. Regenerating liver KC 48 to 120 hours after partial hepatectomy responded to endotoxin stimulation with a significantly greater (p less than 0.05) production of IL-6 in standard RPMI-1640. Because Kupffer cells function in an environment where high arginase activity results in negligible L-arginine levels, the 10 microM L-arginine RPMI-1640 was used to simulate the true hepatic microenvironment. Production of IL-6 by regenerating liver KC was further increased (p less than 0.05) by placing these same KC in 10 microM L-arginine RPMI-1640 tissue culture media. During the same period, regenerating liver KC produced significantly (p less than 0.01) more PGE2 than sham-operated KC in both standard and low-arginine media. When the cyclo-oxygenase inhibitor indomethacin (1 x 10(-5) M) was added to cultures, the PGE2 production was inhibited, and IL-6 production was upregulated (p less than 0.05) in arginine-depleted cultures. The authors conclude that during hepatic regeneration KC IL-6 production is elevated but controlled in an autoregulatory fashion by KC PGE2 production.

Animals↗
PubMed1987

Spontaneous production of a suppressor factor by a human macrophage-like cell line U937. II. Suppression of antigen- and mitogen-induced blastogenesis, IL 2 production and IL 2 receptor expression in T lymphocytes.

U937, a human macrophage-like cell line, spontaneously produces a factor which inhibited blastogenic responses of human blood T lymphocytes stimulated with tuberculin-purified protein derivative (PPD) or phytohemagglutinin (PHA). We investigated the mechanism of suppressor action of the U937 factor. The U937 suppressor factor inhibited interleukin 2 (IL 2) production by human blood T lymphocytes stimulated with PPD or PHA. IL 1 did not overcome the inhibitory action of the U937 factor on PPD-induced IL 2 production by human blood T lymphocytes. The U937 factor also inhibited the production of IL 2 by a human leukemic cell line, JURKAT, stimulated with PHA. The U937 suppressor factor interfered with the expression of Tac antigen (IL 2 receptor) on PPD- or PHA-stimulated blood T lymphocytes. The inhibitory activity of the U937 factor on Tac expression was not affected by the addition of IL 2 or a crude lymphokine-containing T cell supernatant. Tac expression was more sensitive than IL 2 production to inhibition by U937-conditioned medium. The U937 suppressor factor was precipitable by 33 to 67% saturated ammonium sulfate and was inactivated at pH 2 or pH 11. Sephacryl S-200 Gel filtration analysis of U937 culture supernatants revealed that the inhibitory activities for blastogenesis, IL 2 production, and Tac expression co-purified in fractions with an apparent m.w. between 67,000 and 130,000. These data indicate that U937 spontaneously produces a macromolecular suppressive factor with major locus of action on the production of IL 2 and the expression of the IL 2 receptor.

Cell Line↗
PubMed1987

A hollow fibre dialysis system for the in vitro production of monoclonal antibodies replacing in vivo production in mice.

Haemodialysis units have been used as bioreactors for the in vitro production of monoclonal antibodies. Mouse hybridomas were grown in the extra-capillary compartment of dialysis modules with a constant supply of protein-free medium through the hollow fibres. It was found that addition of serum to the media had no stimulatory effect on the production of monoclonal antibodies. For the determination of monoclonal antibodies a sol particle immunoassay (SPIA) has been used. Monoclonal antibodies were harvested from the extra-capillary compartment at two-week intervals over periods of several weeks at concentrations comparable to the harvests of ascitic fluids from mice. The production capacity of one haemodialysis unit is equivalent to that of at least 50 mice. This in vitro system enables a yearly production of 50 grams per unit of monoclonal antibodies of high purity and devoid of contaminants from mouse origin or serum. It has been shown that this system can be successfully used to produce a constant supply of monoclonal antibodies for a variety of applications, e.g. reagents for diagnostic tests and materials for immuno-chromatographic purification. As a consequence this in vitro production of monoclonal antibodies has replaced the many thousands of mice required for in vivo production.

Animals↗
PubMed1984

Beshada v. Johns-Manville Products Corp.: the function of state of the art evidence in strict products liability.

In Beshada v. Johns-Manville Products Corp., the Supreme Court of New Jersey held that a state of the art defense is unavailable in cases brought under a theory of strict liability for failure to warn. The court indicated that asbestos producers may be held liable for their products' harms even if the health hazards of asbestos were unknown and not discoverable when the products were marketed. In a subsequent case, the New Jersey court held that state of the art evidence is relevant to whether a product is defective. This Case Comment examines these different uses of knowledge evidence in the disposition of products liability cases. It contends that manufacturers should not be held liable for unknowable risks. The Comment concludes that the state of the art defense establishes a logical limit on strict liability and promotes efficient resolution of products liability claims.

Asbestos↗